Headache associated with sexual activity
Methodology & AI Transparency ⓘ
Headache associated with sexual activity Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Recognized across U.S.
- 2 Real-world patient consensus: Diagnostic registry G44.82: Headache associated with sexual activity is managed within Migraine & Headache.
- 3 Typical cash cost range: Clinicians assessing Headache associated with sexual activity focus on dural neurogenic vasodilation [Headache associated with sexual activity G44.82] and targeted history.
- 4 Top reported side effects / signs: Objective lab/clinical target for Headache associated with sexual activity: MIDAS Disability Score [Headache associated with sexual activity G44.82] (Grade I (0 – 5) (G44.82)) and RBC Magnesium & in Headache associated with sexual activity (G44.82: Riboflavin Status).
Ask our AI Specialists anything about Headache associated with sexual activity
What Is Headache associated with sexual activity?
Recognized across U.S. clinical coding as G44.82 (Migraine & Headache), Headache associated with sexual activity is evaluated via ICHD-3 clinical headache in Headache associated with sexual activity (G44.82: diary classification) to align day-to-day symptom relief with long-term physiological stability.
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Headache associated with sexual activity (ICD-10 G44.82) is driven by dural neurogenic vasodilation [Headache associated with sexual activity G44.82]; specialists in Migraine & Headache Disorders monitor RBC Magnesium & in Headache associated with sexual activity (G44.82: Riboflavin Status) to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Presentation of Headache associated with sexual activity (G44.82): heightened sensitivity to in Headache associated with sexual activity (G44.82: bright light)
- • Secondary Headache associated with sexual activity clinical sign: visual aura [Headache associated with sexual activity G44.82]
- • Symptom flares in Headache associated with sexual activity correlating with MIDAS Disability Score [Headache associated with sexual activity G44.82] deviation outside Grade I (0 – 5) (G44.82)
- • Functional migraine & headache impact requiring ICHD-3 clinical headache in Headache associated with sexual activity (G44.82: diary classification) evaluation (G44.82)
Headache associated with sexual activity Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | G44.82 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Migraine & Headache Disorders | NLM Clinical Tables |
| Diagnostic / Lab Marker: MIDAS Disability Score [Headache associated with sexual activity G44.82] | Grade I (0 – 5) (G44.82) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: RBC Magnesium & in Headache associated with sexual activity (G44.82: Riboflavin Status) | RBC Mg 5.0 – 6.4 mg/dL (G44.82) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Monthly Headache Days in Headache associated with sexual activity (G44.82: (MHD)) | < 2 days/month on prevention (G44.82) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Headache associated with sexual activity
Treatment selection for Headache associated with sexual activity depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Headache associated with sexual activity)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Eptinezumab improved patient-reported outcomes in patients with migraine and: What a 1,072-Participant Study Found This subgroup analysis in patients with CM/MOH at baseline suggests that eptinezumab treatment is associated with early, sustained, and clinically meaningful improvements in patient-reported outcomes. Headache • 2023-02-15 • Phase III Randomized Trial | N = 1,072 | 96/100 | PMID 36633219 ↗ |
| New Insights on Early onset of efficacy with fremanezumab in patients with episodic and chronic: What a 357-Participant Study Found These results suggest that fremanezumab has an early onset of action, as noted in previous post hoc analyses of anti-CGRP monoclonal antibodies. The journal of headache and pain • 2022-02-09 • Phase III Randomized Trial | N = 357 | 93/100 | PMID 35139816 ↗ |
| New Insights on Efficacy and quality-of-life improvements with fremanezumab treatment in patients: What a 838-Participant Study Found Fremanezumab reduced days with neurological symptoms, effectively prevented migraine, and improved quality of life in patients with migraine with associated neurological dysfunction, including. European journal of neurology • 2022-07-15 • Phase III Randomized Trial | N = 838 | 93/100 | PMID 35302681 ↗ |
| New Insights on Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in: What a 538-Participant Study Found A single dose of rimegepant 75 mg rimegepant was effective for the acute treatment of migraine in adults living in China, with safety and tolerability similar to placebo. The journal of headache and pain • 2024-04-16 • Phase III Randomized Trial | N = 538 | 93/100 | PMID 38627638 ↗ |
| New Insights on Changes in patient functioning and disability: results from a phase 3,: What a 558-Participant Study Found Galcanezumab-treated patients with chronic migraine reported statistically significant improvements in functioning and disability, representing a clinically significant change. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation • 2021-01-15 • Phase III Randomized Trial | N = 558 | 93/100 | PMID 32930994 ↗ |
Headache associated with sexual activity Patient Community & “People Like Me” Threads
Filter Headache associated with sexual activity community threads and patient logs by age, biological sex, dosage, and treatment duration.